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Abstract
Background: Propensity scores are typically applied in retrospective cohort studies. We describe the feasibility of
matching on a propensity score derived from a retrospective cohort and subsequently applied in a prospective
cohort study of patients with chronic musculoskeletal pain before the start of acupuncture or usual care treatment
and enrollment in a comparative effectiveness study that required patient reported pain outcomes.
Methods: We assembled a retrospective cohort study using data from 2010 to develop a propensity score for
acupuncture versus usual care based on electronic healthcare record and administrative data (e.g., pharmacy) from
an integrated health plan, Kaiser Permanente Northwest. The propensity score’s probabilities allowed us to match
acupuncture-referred and non-referred patients prospectively in 2013-14 after a routine outpatient visit for pain.
Among the matched patients, we collected patient-reported pain before treatment and during follow-up to assess
the comparative effectiveness of acupuncture. We assessed balance in patient characteristics with the post-
matching c-statistic and standardized differences.
Results: Based on the propensity score and other characteristics (e.g., patient-reported pain), we were able to
match all 173 acupuncture-referred patients to 350 non-referred (usual care) patients. We observed a residual
imbalance (based on the standardized differences) for some characteristics that contributed to the score; for
example, age, -0.283, and the Charlson comorbidity score, -0.264, had the largest standardized differences. The
overall balance of the propensity score appeared more favorable according to the post-matching c-statistic, 0.503.
Conclusion: The propensity score matching was feasible statistically and logistically and allowed approximate
balance on patient characteristics, some of which will require adjustment in the comparative effectiveness
regression model. By transporting propensity scores to new patients, healthcare systems with electronic health
records can conduct comparative effectiveness cohort studies that require prospective data collection, such as
patient-reported outcomes, while approximately balancing numerous patient characteristics that might confound
the benefit of an intervention. The approach offers a new study design option.
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Background
Propensity scores are an increasingly popular method of
controlling potential confounding in observational studies
that compare the effectiveness of healthcare interventions
[1, 2]. Propensity scores are typically used in retrospective
cohort studies and involve fitting regression models to
predict treatment groups based on selected characteristics
derived from administrative healthcare data or electronic
health record (EHR) data [2].
To date, propensity score methods have not been used
to recruit and match subjects on an ongoing basis in
prospective cohort studies that require the collection of
patient-reported outcomes (PROs). PROs may be
required at baseline (e.g., to define cohort eligibility or
assess treatment effect heterogeneity) or may be
required as an outcome. Examples of such PRO data
include self-reported measures of depression or pain.
While the systematic collection of PROs in the EHR
remains uncommon in routine practice settings, collec-
tion of PROs is increasing [3].
This paper details a novel use of a propensity score to
permit ongoing matching in a prospective cohort study
comparing the effectiveness of acupuncture versus usual
care to treat pain in patients with chronic musculoskel-
etal pain (CMP). A propensity score offered a more
efficient approach statistically and logistically for enroll-
ment in the prospective cohort study than alternative
study designs. We sought to match on patients’ pre-
treatment Brief Pain Inventory score because it served as
an outcome for evaluating the comparative effectiveness
of acupuncture. The Brief Pain Inventory could only be
collected by interviewing patients; it was not collected
systematically in routine practice. Had we matched on
Brief Pain Inventory score and enrolled patients in the
cohort for additional prospective data collection of
patient reported outcomes, we could have developed a
propensity score after enrollment finished to adjust for
additional patient characteristics that might confound
the acupuncture effect. Some patients on whom we
would have collected patient-reported outcomes would
have been excluded from the analysis because of a lack
of overlap in their propensity scores (i.e., trimming),
which would have resulted in a loss statistically (worse
precision) and a loss logistically (wasted research staff
effort). Given a pre-determined level of research funding,
we sought to invest in prospective data collection for
those patients who would contribute to the estimate of
comparative effectiveness. Using recent historical EHR
and other administrative healthcare data, we developed a
propensity score to predict the probability of referral
and initiation of acupuncture in patients with CMP. We
matched patients by deciles of propensity as we enrolled
them in the prospective cohort study to reduce imbal-
ance in the final comparison groups. Our paper
describes the feasibility of our approach and assesses the
degree of balance in baseline characteristics that we
achieved.
Methods
Our prospective cohort study, the RELIEF study, has
been described elsewhere [4]. Although the design of
RELIEF involved parallel studies of both acupuncture
and chiropractic care for the management of CMP, this
report only describes the acupuncture cohort study. The
prospective cohort study included one cohort of patients
who were referred for acupuncture and a second cohort
of patients who were not referred for acupuncture,
which served as the control cohort. All study procedures
and the study protocol were approved by the Kaiser Per-
manente Northwest (KPNW) Institutional Review Board
(IRB). KPNW is an integrated delivery system that man-
aged healthcare for patients in Oregon and Washington
States in the northwestern United States. KPNW served
as the study’s setting. For the prospective cohort
study—the only portion of the study reported here that
required direct patient contact and consenting—the
KPNW IRB granted a waiver of signed informed consent
and an alteration of the privacy rule authorization
(Health Insurance Portability and Accountability Act,
HIPAA; no signature). Participants provided verbal con-
sent and HIPAA elements were reviewed verbally with
all participants who enrolled in the prospective cohort
study. For the retrospective cohort studies, KPNW’s IRB
granted a waiver of signed informed consent and an al-
teration of the privacy rule authorization. The National
Center for Complementary and Alternative Medicine at
the National Institutes of Health sponsored the study.
The sponsor had no role in the study design, data collec-
tion, data analysis, data interpretation, writing of the
report or decision to submit for publication.
Use of retrospective cohorts to develop and validate the
propensity score
We identified adult members at KPNW, an integrated
delivery system with approximately 480,000 members,
who had a diagnosis for chronic pain documented in the
EHR on at least three pain-related outpatient visits over
a six to 18-month period. The pain had to be chronic in
that it occurred over at least six months. We allowed up
to 18 months for patients to meet the criteria for three
pain-related visits. One of the three pain-related visits
had to include a diagnosis of chronic musculoskeletal
pain. We excluded patients with cancer, dementia,
psychoses (or transient psychotic episodes), and those in
hospice.
From that source population, we identified patients
with subsequent referral and documented use of acu-
puncture during 2010. We also identified a comparison
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group of patients who met the same eligibility criteria
but who had no evidence of subsequent referral and use
of acupuncture after their most recent visit for chronic
pain in 2010. We then excluded patients with a recent
prior referral for acupuncture or use of acupuncture
(within the past six months) because a valid propensity
score requires incident users [5]. Patients were insured
by KPNW continuously for at least six months before
the index primary care visit for chronic pain (i.e., the
visit associated with acupuncture referral or the most
recent pain-related visit for the comparison cohort).
We then developed a propensity score model to
predict initiation of acupuncture using logistic regression
[6]. Potential variables for inclusion in the model
included information available from the EHR and related
administrative databases, such as outpatient pharmacy
prescription fills. A complete list of the diagnosis, pro-
cedure and medication codes is available upon request.
In broad categories, the candidate characteristics in-
cluded: age; the frequency of recent outpatient
utilization (e.g., all outpatient visits, physical therapy
visits); behaviors and symptoms (e.g., smoking, sub-
stance abuse, sleep problem); treatments for pain (e.g.,
medications and procedures); and outpatient diagnoses
(e.g., pain-specific as well as the Charlson comorbidity
score).
In deciding on the predictor characteristics for the
propensity score, we consulted physicians with expertise
in pain who considered whether the characteristic would
be likely to predict initiation of acupuncture, and separ-
ately, to predict pain (the primary outcome for the pro-
spective cohort to estimate comparative effectiveness).
Characteristics that meet those criteria are more effect-
ive at reducing confounding and less likely to inflate the
treatment effect confidence interval [7]. We excluded
predictor characteristics with a very low prevalence
because the coefficients in the propensity score would
be less reliable (imprecise) for future application in the
prospective cohort study [8]. We specified the predictor
characteristics a priori in consultation with physicians
instead of using statistical significance or other data-
dependent variable reduction strategies. Our a priori
strategy reduced optimism in the propensity score coef-
ficients that would have reduced its effectiveness in
future populations [9]. To assess how well the propen-
sity score from 2010 might predict in subsequent popu-
lations, we conducted a temporal validation using
KPNW data from 2011. The temporal validation
assessed the propensity score’s ability to discriminate be-
tween future patients who initiate acupuncture and
those who do not initiate acupuncture. We used the
concordance statistic (c-statistic) to measure discrimina-
tive ability, which is equivalent to the area under the
receiver operating characteristic curve [9]. We assessed
the agreement between the observed and predicted
probabilities of referral to measure calibration [9].
Prospective cohort that matched on the propensity score
We were able to identify eligible patients with a referral
for acupuncture during 2013 or 2014 before they began
acupuncture because the EHR is updated daily. This
timely identification also allowed us to recruit referred
patients and to screen them for study eligibility before
treatment. The eligibility criteria were similar to those
defined for the retrospective cohorts described above
with the following exception: we did not require patients
to initiate acupuncture. For any given referral patient,
we identified potential controls as chronic musculoskel-
etal pain patients with a recent (preceding 10 days) visit
for pain that did not result in a referral for acupuncture.
Staff screened all patients for eligibility by telephone or
through a study website to collect patient-reported infor-
mation that was not documented in the EHR. We
excluded patients who reported any of the following
(Fig. 1):
 Declined to be screened for the prospective cohort
study
 < 4 on the (0–10 scale) for Brief Pain Inventory
bothersomeness score
 Non-persistent pain
 Already started acupuncture at KPNW (i.e., we
could not obtain pre-treatment measures)
 Recent undocumented use of acupuncture (i.e.,
outside of KPNW in past six months)
 Pregnant
 Intended to move out of state (i.e., patients would
be lost to follow-up).
Among eligible patients referred for acupuncture, we
calculated the probability of acupuncture initiation using
the propensity score equation developed with the retro-
spective cohort from 2010. A patient with a referral
order for acupuncture documented on Monday, for ex-
ample, would be screened as soon as possible—typically
within three days. If the patient were eligible according
to the criteria noted above, he or she would be “scored”
according to the propensity score. The predicted prob-
ability of acupuncture initiation for this patient might be
0.05, which would map to one of the deciles defined by
the 2010 score.
In parallel, we recruited control patients who were not
referred for acupuncture. Control patients were matched
on propensity score decile as well as sex and the Brief
Pain Inventory bothersomeness item (+/- two points on
the 10-point scale) as assessed during screening [10].
Propensity score deciles were defined by the observed
distribution rather than deciles of absolute risk (e.g., the
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third decile was the third decile of the propensity score
distribution, and not those with predicted probability of
acupuncture use between 20 and 30%). We screened up
to 15 control patients per acupuncture-referred patient
to obtain a match. Our goal was to match two control
patients per acupuncture-referred patient. When we
found more than two control patients who met our
matching criteria based on the propensity score decile,
sex and Brief Pain Inventory bothersomeness, we se-
lected control patients with the most recent visit for
pain. For example, if the patient referred for acupunc-
ture had been screened for the study within three days
of the referral, we sought control patients who had been
screened within three days (or as close as possible) of
their most recent visit for pain.
Some eligible patients who consented to the screening
declined to participate in the prospective cohort study
and were excluded (n = 79) from the analysis. The Figure
illustrates the number of patients who were screened,
eligible, matched, and consented to participate in the
prospective study.
Assessing balance in predictors
We calculated the standardized difference for each of
the characteristics to assess the degree of the imbalance
in baseline (pre-treatment) predictor characteristics that
might confound estimates of comparative effectiveness.
For continuous measures, the standardized difference is
defined as the difference in means divided by the pooled
standard deviation, and for binary data as 2*[arcsin(√P1)
– arcsin(√P2)] [11]. We used the unadjusted standard
deviation for the standardized differences presented in
Table 1 to make the comparison between adjusted and
unadjusted standardized differences more meaningful.
Larger differences in the standardized differences indi-
cate worse discrepancies.
We also calculated c-statistics for our propensity score
models. C-statistics are traditionally used to measure the
discriminatory power of a predictive model, and for
logistic regression are equivalent to the area under the
receiver operating characteristic curve. Thus, a c-
statistic of 1.0 represents perfect discrimination, while a
c-statistics of 0.5 represents no discrimination between
Fig. 1 Participant flow diagram for the prospective cohort study
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Table 1 Impact of propensity score adjustment for development cohort




Did Not Start Acupuncture
(n = 59,564)
Standardized differencea Standardized differencea
Propensity score characteristicsb
Opioid therapy plan 28.8% 17.8% 0.261 0.023
Physical therapy past 30 days 16.3% 15.1% 0.032 −0.008
Physical therapy past 31–180 days 25.0% 11.1% 0.368 0.018
Physical therapy past 181–365 days 24.5% 12.1% 0.324 0.016
Nonspecific chronic pain 29.6% 14.4% 0.373 0.031
Substance abuse 4.6% 4.1% 0.028 0.003
Sleep problem 23.6% 14.6% 0.232 0.016
History of tobacco use 14.2% 12.9% 0.036 0.000
Anxiety 23.7% 15.6% 0.206 0.017
Pain treatment procedure 38.2% 22.5% 0.344 0.020
Pain diagnosis procedure 65.3% 52.5% 0.261 0.011
Pain medication 81.2% 65.0% 0.370 0.008
Age (years) 53.8 (14.0) 55.2 (15.0) −0.097 −0.008
Number of outpatient visits 15.9 (10.8) 10.4 (10.1) −0.543 0.011
Months since cohort entry 29.1 (14.7) 25.2 (15.6) −0.246 0.010
Ambulatory Charlson score 1.8 (2.2) 1.9 (2.1) −0.036 −0.006
Demographic Characteristics
Female 72. 8% 62.0% 0.232 0.146
White 91.2% 91.9% −0.023 −0.033
Hispanic 5.4% 7.7% −0.091 −0.093
Medical and Psychiatric Comorbidities
Depression 21.5% 15.8% 0.148 0.014
Types of Nonmalignant Chronic Pain (NCP)
Back and/or neck pain 80.6% 55.9% 0.539 0.407
Joint pain (including osteoarthritis) 79.3% 79.3% 0.001 −0.114
Fibromyalgia/other myofascial pain 30.1% 11.8% 0.461 0.257
Headaches 18.0% 12.0% 0.167 0.077
Neuropathy 1.5% 1.5% −0.001 0.011
Temporomandibular disorders 5.0% 3.0% 0.105 0.046
Carpal tunnel syndrome 6.5% 5.8% 0.028 −0.016
Abdominal pain 6.3% 4.8% 0.068 −0.018
Other NCP 5.8% 6.6% −0.034 −0.057
Two of above NCP types 81.1% 60.6% 0.457 0.224
Pharmacotherapy
Any use of an opioid 19.9% 11.8% 0.223 0.025
Opioid morphine equivalent dose (MED) 0.3 (1.7) 0.2 (0.9) 0.122 −0.012
≥ 120 MED 7.9% 4.5% 0.141 −0.007
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those who initiated acupuncture and those who did not
initiate. The c-statistic played no role in our selection of
pre-treatment characteristics (e.g., we did not prefer
larger c-statistics) and should not be interpreted as a
measure of how well the propensity score may control
confounding [12]. Our principal interest in the c-statistic
was to assess the change in the c-statistic between the
propensity score development and temporal validation
cohorts to understand how well the model (from 2010)
transported over time to new patients (2011) [9]. For the
prospective cohort study we calculated a different ver-
sion of the c-statistic, the post-matching c-statistic,
which assesses overall balance in patient characteristics
in the propensity score [13]. For the post-matching c-
statistic, values closer to 0.5 indicate better balance
between the acupuncture-referred and control cohorts.
Results
Development of propensity score model
We used our study-specific chronic pain registry
(current KPNW patients who met our EHR study defin-
ition of likely CMP) to assemble a cohort of 60,516 eli-
gible patients in 2010. Of these, 952 (1.6%) started
acupuncture during 2010. Table 1 shows the baseline
characteristics of the patients who started acupuncture
and those who did not start acupuncture. The character-
istics are presented first for those variables included in
the propensity score model, and then for selected
categories of other variables.
The majority of characteristics included in the propen-
sity score model exhibited differences between the two
patient cohorts. Patients who started acupuncture, for
example, were more likely to have used pain medication
(81.2% vs 65.0%, with a standardized difference of 0.37).
Likewise, most of the pain-related characteristics were
more common among those who started acupuncture
(i.e., opioid therapy plan, non-specific chronic pain, pain
treatment procedure, and pain diagnosis procedure). A
more general measure of comorbidity, the Charlson
score (Deyo’s adaptation), showed a negligible imbalance
with a standardized difference close to zero. The corre-
sponding c-statistic for the variables in the propensity
score model was 0.739, which reflects the broad imbal-
ance between the cohorts in these variables and the
propensity score model’s ability to discriminate between
the cohorts. After adjusting for propensity score decile
using 10 indicator variables, however, the balance of the
characteristics in the propensity score model improved.
All of the standardized differences were close to zero
and no values were greater than 0.05 or less than -0.05.
Many of the characteristics that were not included in
the propensity score model were also imbalanced
between patients who started acupuncture and those
who did not (Table 1). Back or neck pain and fibromyal-
gia (or other myofascial pain) were more common
among the patients who started acupuncture. Multiple
types of pain were more common among the patients
who started acupuncture: 81.1% vs 60.6%, a standardized
difference of 0.46. Opioid use was more common among
the patients who started acupuncture: 19.9% vs 11.8%, a
standardized difference of 0.223. Adjustment for propen-
sity score decile also improved the balance for some of
these characteristics.
The propensity score model developed with data from
2010 validated adequately in a distinct cohort of patients
from 2011 (c-statistic = 0.708, without matching). The
propensity score’s agreement between predicted and
observed probabilities of acupuncture initiation was also
adequate (calibration plot not shown).
Use of the propensity score model for recruitment into
the prospective cohort study
We identified 1154 patients referred for acupuncture
from the study-specific chronic pain registry and invited
them to be screened for the prospective cohort study
(Fig. 1). Some patients agreed to be screened according
to the study’s eligibility criteria; those patients took the
screener’s survey. Patients were ineligible if any of the
following were true:
 Patient scored < 4 on the Brief Pain Inventory’s pain
bothersome scale (ranged from 0 to 10).
 Patient’s pain was not chronic.
 Patient had a recent history (past six months) of
undocumented acupuncture performed outside of
KPNW.
 Patient had already started acupuncture at KPNW
and we could not obtain pre-treatment measures.
Table 1 Impact of propensity score adjustment for development cohort (Continued)
Mental health related
Any antidepressant use 47.6% 35.4% 0.247 0.036
Any anxiolytic use 33.1% 21.2% 0.270 0.041
Any benzodiazepine use 35.4% 21.1% 0.321 0.067
aStandardized difference expressed as (difference in means)/(pooled standard deviation) for continuous measures and as 2*(arcsin(√P1)-arcsin(√P2)) for binary
data. For propensity score decile adjusted data, standardized differences calculated using same standard deviation as for unadjusted data in order to make
comparison of standardized differences with and without adjustment more meaningful
bContinuous data expressed as mean (standard deviation)
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 Patient was pregnant.
 Patient intended to move outside of the KPNW
coverage area and would be lost to follow-up.
We screened 414 (36%) patients and determined that
252 patients were eligible for the acupuncture-referred
cohort. As those 252 patients became eligible we calcu-
lated their propensity scores. The matching of control
patients occurred in two steps. Once we identified an
eligible patient referred for acupuncture, we selected a
pool of possible control patients whose propensity score
probability was in the same decile as the acupuncture-
referred patient. Control cohort patients were not
referred for acupuncture but had a recent pain-related
visit. At that stage, the possible controls were only
matched on the propensity score decile and control
patients were invited to be screened according to the
criteria listed above. In most instances, we identified
more possible controls than required to match two con-
trol patients, so the majority were closed-out and never
screened (n = 6698). A total of 1013 control cohort
patients agreed to take the screener’s survey and 257
patients were ineligible according to the criteria.
The second step in matching occurred for the 756
control cohort patients who screened eligible: Control
patients had to match on sex and Brief Pain Inventory
bothersome score. Some of the eligible patients were not
enrolled; they were closed out of the study for the fol-
lowing reasons: (1) The patient could not be matched on
the patient-reported Brief Pain Inventory score (which
was only collected during screening) and sex; (2) the
patient was no longer required as a control because we
had already identified two control patients for the
patient referred for acupuncture; (3) the patient experi-
enced technical problems with the online enrollment
process, which occurred more commonly in the early
study recruitment. A few patients refused to participate
in the prospective cohort study. After all of those con-
siderations itemized in the Figure, 350 control cohort
patients consented to the prospective cohort study.
Control patients were frequency-matched to 173
acupuncture-referred patients.
Table 2 shows the baseline characteristics of the 523
patients in the prospective cohort study. The cohorts are
by definition already adjusted for the propensity score
because the non-referred group was matched on decile
of propensity score as part of the selection process.
Hence, further analytic adjustment for decile of propen-
sity score was unnecessary. As a result, Table 2 only
presents one standardized difference estimate (without
additional analytic adjustment for decile of propensity
score). Most of the balance achieved by traditional
adjustment for propensity score in Table 1 was retained
via the matching process used to select the prospective
cohort study sample. For example, the overall use of any
pain medication was 57.8% (acupuncture-referred) ver-
sus 56.0% (control). The standardized differences (abso-
lute values) ranged from 0.010 (physical therapy 31 to
180 days before the start of follow-up) to 0.283 (age).
After age, the least balanced characteristics ranked by
standardized difference were: comorbidity (as measured
by the Deyo adaptation of the Charlson score), -0.264;
physical therapy in the 181 to 365 days before the start
of follow-up, 0.244; an opioid therapy plan, -0.239; a
sleep problem, 0.142, physical therapy in the past
30 days, -0.141, months since cohort entry, -0.114; and,
a pain diagnosis procedure, -0.104. The overall balance
was more reassuring with a post-matching c-statistic of
0.503 (where 0.500 would indicate perfect balance; for
example, randomization assignment in a trial would not
discriminate patients’ treatment). The post-matching c-
statistic should be interpreted differently from the (un-
matched) c-statistics reported above for the development
and validation cohorts.
We also evaluated characteristics that may predict pain
and confound the estimate of comparative effectiveness,
but were not in the propensity score. The least balanced
characteristics ranked by standardized difference were:
fibromyalgia or other myofascial pain, 0.327; headaches,
0.252; neuropathy, -0.240; back or neck pain, 0.223;
white race, -0.176; two types of non-chronic pain, 0.132;
carpal tunnel syndrome, -0.116; antidepressant medica-
tion use, 0.110, and depression, -0.109.
Discussion
We implemented a novel application of a propensity
score in which we initially developed a propensity score
in one cohort of patients and then used that propensity
score to match patients on an ongoing basis in a distinct
prospective cohort study to evaluate the comparative ef-
fectiveness of acupuncture. Our development cohort
demonstrated that providers refer—and patients initia-
te—acupuncture preferentially according to measured
patient characteristics, including markers of chronic pain
severity (e.g., pain medications generally and opioid use
specifically). Our prospective cohort demonstrated that
propensity score matching provided approximate bal-
ance across the variables used to fit the propensity score
model and additional variables not included as part of
the propensity score model. However, some of the pa-
tient characteristics that were imbalanced (e.g., age) will
require adjustment in the comparative effectiveness
regression model to reduce residual confounding.
Our prospective cohort study compared patients with
chronic musculoskeletal pain who were referred for
acupuncture with those who were not referred for
acupuncture. Some characteristics appeared imbalanced
in the prospective cohort study based on their
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Table 2 Impact of propensity score matching for prospective cohort
Referred for Acupuncture
(n = 173)




Opioid therapy plan 20.2% 30.6% −0.239
Physical therapy past 30 days 1.2% 3.1% −0.141
Physical therapy past 31–180 days 11.6% 8.6% 0.010
Physical therapy past 181–365 days 16.2% 8.3% 0.244
Nonspecific chronic pain 30.1% 30.0% 0.013
Substance abuse 5.2% 3.7% 0.072
Sleep problem 26.0% 20.0% 0.143
History of tobacco use 24.9% 27.1% −0.052
Anxiety 21.7% 18.5% −0.080
Pain treatment procedure 18.5% 22.0% −0.087
Pain diagnosis procedure 46.2% 51.4% −0.104
Pain medication 57.8% 56.0% 0.036
Age (years) 49.6 (11.8) 52.8 (11.5) −0.283
Number of outpatient visits 10.3 (8.0) 10.8 (8.2) −0.062
Months since cohort entry 42.4 (27.7) 45.5 (26.9) −0.114
Ambulatory Charlson score 1.1 (1.4) 1.5 (2.0) −0.264
Characteristics that did not contribute to the propensity score
Demographic Characteristics
Female 71.1% 73.7% −0.059
White 88.5% 93.5% −0.176
Hispanic 3.8% 4.1% −0.016
Medical and Psychiatric Comorbidities
Depression 12.7% 16.6% −0.109
Types of Nonmalignant Chronic Pain (NCP)
Back and/or neck pain 71.1% 60.6% 0.223
Joint pain (including osteoarthritis) 66.5% 70.9% −0.095
Fibromyalgia/other myofascial pain 30.6% 16.9% 0.327
Headaches 20.2% 11.1% 0.252
Neuropathy 3.5% 9.1% −0.240
Temporomandibular disorders 2.9% 2.6% 0.020
Carpal tunnel syndrome 2.9% 5.1% −0.116
Abdominal pain 11.0% 9.4% 0.051
Other NCP 5.2% 5.1% 0.003
Two of above NCP types 74.0% 68.0% 0.132
Pharmacotherapy
Any use of an opioid 20.2% 21.7% −0.036
Opioid morphine equivalent dose (MED) 0.3 (1.1) 0.3 (1.1) −0.026
≥ 120 MED 7.5% 8.6% −0.039
Mental health related
Any antidepressant use 54.9% 49.4% 0.110
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standardized differences, which were as large as -0.283
(e.g., age). In contrast, the overall balance was adequate
based on the post-matching c-statistic (0.503), which
exhibited little room for improvement relative to a score
of 0.5 that would be expected with randomly-generated
treatment assignments [12]. Although simulations have
demonstrated that the post-matching c-statistic offers a
valid assessment of covariate balance in retrospective
cohort studies for which the propensity score is both
developed and applied through matching in the same
population, [13] we know little about its interpretation
when the propensity score is transported to a distinct
population with a different patient case-mix. Conse-
quently, we emphasize the standardized differences in
assessing the magnitude of imbalance.
This study adds important data to the growing body of
literature describing interventions that used propensity
scores [14, 15]. A recent systematic review of studies
that applied propensity scores to control confounding
reported that a minority (17%) of published studies eval-
uated clinical interventions other than surgery or medi-
cations [15]. We are aware of only two studies of
acupuncture that have applied propensity scores tech-
niques, and both studies applied propensity scores in
retrospective studies (i.e., matching on characteristics
and evaluating outcomes previously documented in the
clinical record) [16, 17]. We think that our current study
represents a unique application of propensity scoring.
Had it been feasible to compare the effectiveness of
acupuncture (versus no acupuncture) based on an out-
come that did not require collecting patient-reported
outcomes (PROs), we could have conducted the cohort
study on a broader population of treated and untreated
patients without the need for ongoing matching, and
then conducted traditional propensity score adjustment
after the fact. That’s the typical scenario in retrospective
cohort studies of comparative effectiveness or safety of
treatments for pain: the outcome is collected during
routine practice and documented at no expense to the
investigators [18, 19].
Our prospective study required us to collect PROs
before acupuncture treatment and repeatedly during the
six-month follow-up. PROs require patients’ informed
consent and are expensive to collect. As a result, we lim-
ited collection to those patients who met the eligibility
criteria (which depended in part on patients’ PRO values
preceding acupuncture treatment). While we enrolled all
patients referred for acupuncture, we limited data collec-
tion of non-referred patients to those who were matched
on decile of the propensity score. Using this design
meant that we had to calculate each patient’s propensity
score before enrollment in the prospective cohort, which
was only possible using a propensity score developed
using data from an historical cohort of similar patients;
we hoped the historical propensity score would work
well in our prospective cohort. The temporal validation
of the propensity score and the approximate balance in
the prospective cohort, as reported in the Results,
support the effectiveness of this approach.
The matching worked despite several threats to its valid-
ity. First, the propensity score was developed to predict re-
ferral and initiation of acupuncture (i.e., adherence with at
least one session). To serve the needs the prospective study,
we had to enroll patients solely on the basis of referral for
acupuncture (i.e., regardless of follow-up provision of acu-
puncture) in order to collect the needed baseline (pre-treat-
ment) measurements. Because we recruited patients for a
prospective study that required their consent to participate,
our prospective cohort was subject to a potential selection
bias that did not exist for the historical cohort used to de-
velop the propensity score. Finally, we selected the first two
controls patients who met criteria and agreed to participate
to ensure that we could recruit an adequate number of
non-referred, matched controls in a timely manner. As
such, the non-referred patients who replied more quickly
may differ in subtle ways from the larger pool of potential
controls. This could introduce selection bias between those
referred and not referred for acupuncture. While a combin-
ation of these factors could limit the effectiveness of the
propensity score matching, our final referred and non-
referred cohorts were approximately balanced.
Using propensity scores in prospective cohort studies
is statistically and logistically feasible for health plans
with electronic health records and integrated data. Their
use, however, requires significant resources, including
substantial effort during the period of recruitment,
including ongoing analytic support. For example, infor-
mation from a number of different data sources (EHR,
online survey response databases, interviewer tracking
system) had to be brought together in real time to iden-
tify potential comparison participants and enroll them in
the study, which required a complex set of data
Table 2 Impact of propensity score matching for prospective cohort (Continued)
Any anxiolytic use 28.3% 28.3% 0.001
Any benzodiazepine use 28.9% 27.1% 0.039
aStandardized difference expressed as (difference in means)/(pooled standard deviation) for continuous measures and as 2*(arcsin(√P1)-arcsin(√P2)) for binary
data. For propensity score decile adjusted data, standardized differences calculated using same standard deviation as for unadjusted data in order to make
comparison of standardized differences with and without adjustment more meaningful
bContinuous data expressed as mean (standard deviation)
Johnson et al. BMC Medical Research Methodology  (2017) 17:42 Page 9 of 11
transfers. The identification process could fail at various
points. Accordingly, time devoted to building and main-
taining this system, along with computational needs,
were substantially greater than anticipated. Further,
when system glitches occurred (sometimes due to
unanticipated health service coding changes within the
health care systems), recruitment processes needed to be
suspended until the problem was adjudicated and
systems were realigned. These challenges limited overall
study recruitment.
While using this method was labor-intensive, the
application of this new use of propensity score method-
ology may become increasingly efficient with more ex-
perience [20]. For example, we realized that we could
build a somewhat simpler tracking system that would
have increased the efficiency of the process. While such
efficiencies are possible, the general feasibility of the ap-
proach appears limited to settings with electronic health
records that will allow for the development of propensity
scores (using historical data) and automated calculation
of predicted treatment probabilities for recruitment and
matching on a daily basis in prospective patients.
Conclusion
Whenever investigators need to collect data prospect-
ively in a cohort study evaluating comparative effective-
ness, this approach may save time and money as well as
reduce participant burden by collecting data only from
patients who will contribute to the analysis. Prospective
data collection is often required for behavioral health
interventions, which depend on patient-reported covari-
ates and outcomes, such as depression or pain. Prospect-
ive data collection is also required for many clinical
studies, such as detailed clinical evaluations (e.g., the
New York Heart Association class for heart failure),
expensive laboratory tests, and diagnostic imaging. In
these instances, prospective data collection may improve
control of confounding as well as the assessment of
treatment effect heterogeneity [21]. Our study demon-
strated the feasibility of matching on a propensity score
in a prospective cohort study before the start of treat-
ment to improve the efficiency of data collection while
approximately balancing the cohorts on a larger number
of patient characteristics (to reduce confounding).
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